What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

被引：207

作者：

Finelli, Carmine ^{[1
,2
]}

Tarantino, Giovanni ^{[1
,2
]}

机构：

[1] Stella Maris Mediterraneum Fdn, Ctr Obes & Eating Disorder, I-80035 Potenza, Italy

[2] Univ Naples Federico II, Med Sch Naples, Dept Clin & Expt Med, I-80131 Naples, Italy

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2013年 / 19卷 / 06期

关键词：

Non-alcoholic fatty liver disease; Obesity; Adiponectin; Visceral fat; Adipokines; HIGH-MOLECULAR-WEIGHT; ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ADIPOSE-TISSUE; VISCERAL FAT; METABOLIC SYNDROME; ADAPTER PROTEIN; SKELETAL-MUSCLE; KEY ADIPOKINE;

D O I：

10.3748/wjg.v19.i6.802

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

Non-alcoholic fatty liver disease (NAFLD) is recognized as the most common type of chronic liver disease in Western countries. Insulin resistance is a key factor in the pathogenesis of NAFLD, the latter being considered as the hepatic component of insulin resistance or obesity. Adiponectin is the most abundant adipose-specific adipokine. There is evidence that adiponectin decreases hepatic and systematic insulin resistance, and attenuates liver inflammation and fibrosis. Adiponectin generally predicts steatosis grade and the severity of NAFLD; however, to what extent this is a direct effect or related to the presence of more severe insulin resistance or obesity remains to be addressed. Although there is no proven pharmacotherapy for the treatment of NAFLD, recent therapeutic strategies have focused on the indirect upregulation of adiponectin through the administration of various therapeutic agents and/or lifestyle modifications. In this adiponectin-focused review, the pathogenetic role and the potential therapeutic benefits of adiponectin in NAFLD are analyzed systematically. (C) 2013 Baishideng. All rights reserved.

引用

页码：802 / 812

页数：11

共 142 条

[1]

High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase [J].